C3 variants identified in this study are located in the coding region, and the associated Man9 glycan is attached on a domain that is involved in pathogen binding of the complement component C3 [47], thus the influence of this alteration on complement activation in type 1 diabetes presents an interesting target for future studies. Here, MAN1A1 is linked to type 1 diabetes mellitus.